From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis

Introduction: The discovery of neurotrophic tyrosine receptor kinase (NTRK) gene fusions has facilitated the development of precision oncology. Two first-generation NTRK inhibitors (larotrectinib and entrectinib) are currently approved for the treatment of patients with solid tumors harboring NTRK g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Zhiwei Cui (Autor), Zhen Zhai (Autor), De Xie (Autor), Lihui Wang (Autor), Feiyan Cheng (Autor), Siyu Lou (Autor), Fan Zou (Autor), Rumeng Pan (Autor), Shixue Chang (Autor), Haoyan Yao (Autor), Jing She (Autor), Yidan Zhang (Autor), Xinyuan Yang (Autor)
Formato: Livro
Publicado em: Frontiers Media S.A., 2024-01-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Número de Chamada: A1234.567
Cópia 1 Disponível